New drug JPH034 enters first human safety tests
NCT ID NCT07534657
First seen Apr 19, 2026 · Last updated May 13, 2026 · Updated 3 times
Summary
This early-stage study is testing a new drug, JPH034, in 40 healthy adults aged 18 to 50. Participants receive either the drug or a placebo to check for side effects and measure how the drug moves through the body. The goal is to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Axis Clinicals Phase 1 Unit
RECRUITINGDilworth, Minnesota, 56529, United States
Conditions
Explore the condition pages connected to this study.